Current Problems in Pediatric and Adolescent Health Care
Volume 37, Issue 9 , Pages 338-362 , October 2007

Global Child Health: Burden of Disease, Achievements, and Future Challenges

References 

  1. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year?. Lancet. 2003;361:2226–2234
  2. United Nations. General assembly, 56th session (Road map towards the implementation of the United Nations millennium declaration: report of the Secretary-General (UN document no. A/56/326)). New York: United Nations; 2001;[cited June 20, 2007]. Available from: http://www.un.org/documents/ga/docs/56/a56326.pdf.
  3. WHO. The World Health Report 2005: Making Every Mother and Child Count. Geneva: WHO; 2005;[cited April 27, 2007]. Available from: http://www.who.int/whr/2005/en/.
  4. UNICEF. Progress for Children. A Child Survival Report Card. Vol 1. New York: UNICEF, 2004 [cited May 2, 2007]. Available from: http://www.unicef.org/publications/index_23557.html.
  5. Victora CG, Wagstaff A, Schellenberg JA, Gwatkin D, Claeson M, Habicht JP. Applying an equity lens to child health and mortality: more of the same is not enough. Lancet. 2003;362:233–241
  6. Caulfield LE, de Onis M, Blossner M, Black RE. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr. 2004;80:193–198
  7. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003;81:197–204
  8. Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, et al. Rotavirus vaccines: current prospects and future challenges. Lancet. 2006;368:323–332
  9. Podewils LJ, Mintz ED, Nataro JP, Parashar UD. Acute, infectious diarrhea among children in developing countries. Semin Pediatr Infect Dis. 2004;15:155–168
  10. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565–572
  11. Hart CA, Cunliffe NA, Bresee JS. Diarrhoea caused by viruses. In:  Cook GC,  Zumla A editor. Manson’s tropical diseases. 21st Edition. London: Elsevier Science; 2003;p. 823–830
  12. Cheng AC, McDonald JR, Thielman NM. Infectious diarrhea in developed and developing countries. J Clin Gastroenterol. 2005;39:757–773
  13. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti DJ, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ. 1999;77:651–666
  14. Thapar N, Sanderson IR. Diarrhoea in children: an interface between developing and developed countries. Lancet. 2004;363:641–653
  15. Bhutta ZA. Post-infectious persistent diarrhoea. In:  Southall D,  Coulter B,  Ronald C,  Nicholson S,  Parke S editor. International child health care: a practical manual for hospitals worldwide. 1st Edition. London: BMJ Books; 2002;p. 283–286
  16. Keusch GT, Fontaine O, Bhargava A, Boschi-Pinto C, Bhutta ZA, Gotuzzo E, et al. Diarrheal diseases. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB, et al. editor. Disease control priorities in developing countries. 2nd Edition. New York: Oxford University Press; 2006;p. 371–388[cited May 10, 2007]. Available from: http://www.dcp2.org/pubs/DCP.
  17. Sentongo TA. The use of oral rehydration solutions in children and adults. Curr Gastroenterol Rep. 2004;6:307–313
  18. Victora CG, Bryce J, Fontaine O, Monasch R. Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ. 2000;78:1246–1255
  19. WHO. Implementing the new recommendations on the clinical management of diarrhea: guidelines for policy makers and programme managers. Geneva: WHO; 2006;[cited May 22, 2007]. Available from: http://www.who.int/child-adolescent-health/publications/CHILD_HEALTH/ISBN_92_4_159421_7.htm.
  20. Hahn S, Kim Y, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review. BMJ. 2001;323:81–85
  21. Salam MA, Bennish ML. Antimicrobial therapy for shigellosis. Rev Infect Dis. 1991;13(Suppl 4):S332–S341
  22. Niyogi SK. Shigellosis. J Microbiol. 2005;43:133–143
  23. UNICEF. Pneumonia: The Forgotten Killer of Children. New York: UNICEF; 2006;[updated September 2006; cited 2007 April 25]. Available from: http://childinfo.org/areas/ari/.
  24. Cashat-Cruz M, Morales-Aguirre JJ, Mendoza-Azpiri M. Respiratory tract infections in children in developing countries. Semin Pediatr Infect Dis. 2005;16:84–92
  25. Schuchat A, Dowell SF. Pneumonia in children in the developing world: new challenges, new solutions. Semin Pediatr Infect Dis. 2004;15:181–189
  26. Simoes EAF, Cherian T, Chow J, Shahid-Salles S, Laxminarayan R, John TJ. Acute respiratory infections in children. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB, et al. editor. Disease control priorities in developing countries. 2nd Edition. New York: Oxford University Press; 2006;p. 483–497[cited 2007 May 10]. Available from: http://www.dcp2.org/pubs/DCP.
  27. Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis. 2003;3:547–556
  28. WHO. Technical updates of the guidelines on Integrated Management of Childhood Illness (IMCI): evidence and recommendations for further adaptations. Geneva: WHO; 2005;[cited 2007 April 27]. Available from: http://www.who.int/child-adolescent-health/publications/IMCI/ISBN_92_4_159348_2.htm.
  29. Addo-Yobo E, Chisaka N, Hassan M, Hibberd P, Lozano JM, Jeena P, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet. 2004;364:1141–1148
  30. WHO. WHO vaccine-preventable diseases: monitoring system (2006 Global Summary). Geneva: WHO; 2006;[cited 2007 April 25]. Available from: http://www.who.int/vaccines-documents/DocsPDF05/WHO_IVB_2005.pdf.
  31. Brenzel L, Wolfson L, Fox-Rushby J, Miller MA, Halsey NA. Vaccine-preventable diseases. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB, et al. editor. Priorities in developing countries. 2nd Edition. New York: Oxford University Press; 2006;p. 389–411[cited 2007 May 10]. Available at: http://www.dcp2.org/pubs/DCP.
  32. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004;189(Suppl 1):S4–S16
  33. WHO. Global Immunization Data. Geneva: WHO; 2004;[cited 2007 April 25]. Available from: http://www.who.int/immunization_monitoring/data/GlobalImmunizationData.pdf.
  34. Cook TM, Protheroe RT, Handel JM. Tetanus: a review of the literature. Br J Anaesth. 2001;87:477–487
  35. Vandelaer J, Birmingham M, Gasse F, Kurian M, Shaw C, Garnier S. Tetanus in developing countries: an update on the maternal and neonatal tetanus elimination initiative. Vaccine. 2003;21:3442–3445
  36. Centers for Disease Control (CDC). Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015. MMWR Morb Mortal Wkly Rep. 2006;55:511–515
  37. WHO. Progress towards Global Immunization Goals - 2005: Summary presentation of key indicators. Geneva, 2006 [cited 2007 May 19]. Available from: http://www.who.int/immunization_monitoring/data/SlidesGlobalImmunization.pdf.
  38. World Health Organization (WHO). Measles Vaccines (WHO Position Paper). Wkly Epidemiolog Rec. 2004;79:130–143
  39. Wolfson LJ, Strebel PM, Gacic-Dobo M, Hoekstra EJ, McFarland JW, Hersh BS. Has the 2005 measles mortality reduction goal been achieved? (A natural history modelling study). Lancet. 2007;369:191–200
  40. World Health Organization (WHO). Position Paper on Haemophilus Influenzae type b conjugate vaccines. Wkly Epidemiolog Rec. 2006;81:445–452
  41. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Nije A, Usen S, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet. 2005;366:144–150
  42. WHO. Selected vaccine introduction status into routine infant immunization worldwide. Geneva: WHO; 2003;[cited 2007 June 20]. Available from: http://www.who.int/immunization_monitoring/routine/schedule_analysis_2003.pdf.
  43. WHO. Pneumococcal conjugate vaccine for childhood immunization—WHO position paper. Wkly Epidemiolog Rec. 2007;82:93–104
  44. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005;365:1139–1146
  45. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003;349:1341–1348
  46. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33
  47. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22
  48. Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD. Rotavirus vaccines: targeting the developing world. J Infect Dis. 2005;192(Suppl 1):S160–S166
  49. WHONICEF. World Malaria Report 2005. Geneva: WHO; 2005;[cited 2007 April 27]. Available at: http://www.rbm.who.int/wmr2005/html/toc.htm.
  50. Greenwood BM, Bojang K, Whitty CJ, Targett GA. Malaria. Lancet. 2005;365:1487–1498
  51. Summer AP, Stauffer WM, Fischer PR. Pediatric malaria in the developing world. Semin Pediatr Infect Dis. 2005;16:105–115
  52. Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg. 2001;64(Suppl 1-2):57–67
  53. Mung’Ala-Odera V, Snow RW, Newton CR. The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa. Am J Trop Med Hyg. 2004;71(Suppl 2):64–70
  54. Roll Back Malaria, WHO. Children and Malaria. Roll Back Malaria Information Sheet [cited 2007 June 20]. Available from: http://www.rbm.who.int/cmc_upload/0/000/015/367/RBMInfosheet_6.htm.
  55. John CC. Pediatric malaria: defining the problem, devising solutions. Presented at Pediatric Academic Societies’ Annual Meeting. Toronto; 2007.
  56. Breman JG, Mills A, Snow RW, Mulligan J, Lengeler C, Mendis K, et al. Conquering malaria. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB, et al. editor. Disease control priorities in developing countries. 2nd Edition. New York: Oxford University Press; 2006;p. 413–431[cited 2007 May 19]. Available from: http://www.dcp2.org/pubs/DCP.
  57. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;(2):CD000363.
  58. Lengeler C, Shapr B. Indoor Residual Spraying and Insecticide-treated Nets. In: Reducing Malaria’s Burden: Evidence of Effectiveness for Decision-Makers. Washington, DC: Global Health Council; 2003;[cited 2007 May 20]. Available from: http://www.globalhealth.org/view_top.php3?id=384.
  59. WHO Global Malaria Programme. Indoor residual spraying: Use of indoor residual spraying for scaling up global malaria control and elimination (WHO Position Statement). Geneva: WHO; 2006;[cited 2007 May 20]. Available from: http://malaria.who.int/docs/IRS-position.pdf.
  60. WHO. WHO gives indoor use of DDT a clean bill of health for controlling malaria. News release. Washington DC; 2006 [cited 2007 May 20]. Available from: http://www.who.int/mediacentre/news/releases/2006/pr50/en/index.html.
  61. Vallely A, Vallely L, Changalucha J, Greenwood B, Chandramohan D. Intermittent preventive treatment for malaria in pregnancy in Africa: what’s new, what’s needed?. Malar J. 2007;6:16
  62. Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molyneux ME. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre (Malawi, in 1997-99). Trans R Soc Trop Med Hyg. 2000;94:549–553
  63. Greenwood B. Review: Intermittent preventive treatment—a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop Med Int Health. 2006;11:983–991
  64. Shetty AK, Woods CR. Prevention of malaria in children. Pediatr Infect Dis J. 2006;25:1173–1176
  65. O’Meara WP, Breman JG, McKenzie FE. The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). Malar J. 2005;4:33
  66. WHO. Taking Stock: HIV in children. Geneva: WHO; 2006;[cited 2007 May 2]. Available from: http://www.who.int/hiv/pub/advocacy/children/en/.
  67. Spira R, Lepage P, Msellati P, Van De Perre P, Leroy V, Simonon A, et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda (Mother-to-Child HIV-1 Transmission Study Group). Pediatrics. 1999;104:e56
  68. Taha TE, Graham SM, Kumwenda NI, Broadhead RL, Hoover DR, Markakis D, et al. Morbidity among human immunodeficiency virus-1-infected and -uninfected African children. Pediatrics. 2000;106:e77
  69. Walker N, Schwartlander B, Bryce J. Meeting international goals in child survival and HIV/AIDS. Lancet. 2002;360:284–289
  70. UNICEF. HIV/AIDS: Preventing Mother to Child Transmission [updated 2006 March; cited 2007 June 20]. Available from: http://childinfo.org/areas/hivaids/mtct.php.
  71. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283:1175–1182
  72. Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2002;(1):CD003510.
  73. Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, Bennish ML, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007;369:1107–1116
  74. Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA. 2006;296:794–805
  75. Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005;19:699–708
  76. WHO. WHO HIV and Infant Feeding Technical Consultation. Consensus Statement. Held on behalf of the Inter-agency Task Team (IATT) on Prevention of HIV Infections in Pregnant Women, Mothers and their Infants. Geneva, 2006 [cited 2007 May 24]. Available from: http://www.who.int/child-adolescent-health/publications/NUTRITION/consensus_statement.htm.
  77. Kline MW. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment. Pediatrics. 2006;117:1388–1393
  78. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis. 2004;8:636–647
  79. Stop TB Partnership Childhood TB Subgroup World Health Organization. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children (Chapter 1: introduction and diagnosis of tuberculosis in children). Int J Tuberc Lung Dis. 2006;10:1091–1097
  80. Nelson LJ, Wells CD. Tuberculosis in children: considerations for children from developing countries. Semin Pediatr Infect Dis. 2004;15:150–154
  81. Enarson PM, Enarson DA, Gie R. Management of tuberculosis in children in low-income countries. Int J Tuberc Lung Dis. 2005;9:1299–1304
  82. Grange JM, Zumla A. Tuberculosis. In:  Cook GC,  Zumla A editor. Manson’s Tropical Diseases. 21st Edition. London: Elsevier Science; 2003;p. 995–1052
  83. Adams LV. Childhood tuberculosis in the developing world. Pediatr Ann. 2004;33:685–690
  84. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995;96(1 Pt. 1):29–35
  85. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006;367:1173–1180
  86. WHO. TB/HIV (A Clinical Manual). 2nd Edition. Geneva: WHO; 2004;[cited 2007 May 2]. Available from: http://www.who.int/tb/publications/who_htm_tb_2004_329/en/index.html.
  87. Neumann CG, Gewa C, Bwibo NO. Child nutrition in developing countries. Pediatr Ann. 2004;33:658–674
  88. Muller O, Krawinkel M. Malnutrition and health in developing countries. CMAJ. 2005;173:279–286
  89. Collins S, Dent N, Binns P, Bahwere P, Sadler K, Hallam A. Management of severe acute malnutrition in children. Lancet. 2006;368:1992–2000
  90. Caulfield LE, Richard SA, Rivera JA, Musgrove P, Black RE. Stunting, wasting, and micronutrient deficiency disorders. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB, et al. editor. Disease control priorities in developing countries. 2nd Edition. New York: Oxford University Press; 2006;p. 551–567[cited 2007 May 10]. Available from: http://www.dcp2.org/pubs/DCP.
  91. Bhan MK, Bhandari N, Bahl R. Management of the severely malnourished child: perspective from developing countries. BMJ. 2003;326:146–151
  92. UNICEF. The 2006 State of the World’s Children (Excluded and Invisible). New York: UNICEF; 2006;[cited 2007 March 28]. Available from: http://www.unicef.org/sowc06/.
  93. Rice AL, Sacco L, Hyder A, Black RE. Malnutrition as an underlying cause of childhood deaths associated with infectious diseases in developing countries. Bull World Health Organ. 2000;78:1207–1221
  94. Bahl R, Frost C, Kirkwood BR, Edmond K, Martines J, Bhandari N, et al. Infant feeding patterns and risks of death and hospitalization in the first half of infancy: multicentre cohort study. Bull World Health Organ. 2005;83:418–426
  95. WHO. Complementary feeding: Report of the global consultation convened jointly by the Department of Child and Adolescent Health and Development and the Department of Nutrition for Health and Development, Geneva, 10-13 December 2001 and Summary of guiding principles for complementary feeding of the breastfed child. Geneva: WHO; 2002;[cited 2007 June 20]. Available from: http://www.who.int/child-adolescent-health/publications/NUTRITION/Report_CF.htm.
  96. Nestel P, Briend A, de Benoist B, Decker E, Ferguson E, Fontaine O, et al. Complementary food supplements to achieve micronutrient adequacy for infants and young children. J Pediatr Gastroenterol Nutr. 2003;36:316–328
  97. Bhutta ZA. Effect of infections and environmental factors on growth and nutritional status in developing countries. J Pediatr Gastroenterol Nutr. 2006;43(Suppl 3):S13–S21
  98. UNICEF. Progress for children: a report card on nutrition (Number 4, May, 2006). New York: UNICEF; 2006;[cited 2007 June 15]. Available from: http://www.unicef.org/progressforchildren/2006n4/index.html.
  99. West KP. Vitamin A deficiency disorders in children and women. Food Nutr Bull. 2003;24(Suppl 4):S78–S90
  100. Ramakrishnan U, Aburto N, McCabe G, Martorell R. Multimicronutrient interventions but not vitamin a or iron interventions alone improve child growth: results of 3 meta-analyses. J Nutr. 2004;134:2592–2602
  101. Beaton GH, Martorell R, Aronson KA, Edmonston B, McCabe G, Ross AC, et al. Vitamin A supplementation and child morbidity and mortality in developing countries. Food Nutr Bull 1993/1994;15 [cited 2007 June 15]. Available from: http://www.unu.edu/unupress/food/8F154e/8F154E00.htm.
  102. Fawzi WW, Chalmers TC, Herrera MG, Mosteller F. Vitamin A supplementation and child mortality (A meta-analysis). JAMA. 1993;269:898–903
  103. UNICEF. UNICEF Statistics: Vitamin A Deficiency [updated 2006 May; cited 2007 June 20]. Available from: http://childinfo.org/areas/vitamina/.
  104. Huiming Y, Chaomin W, Meng M. Vitamin A for treating measles in children. Cochrane Database Syst Rev. 2005;(4):CD001479.
  105. Brown N, Roberts C. Vitamin A for acute respiratory infection in developing countries: a meta-analysis. Acta Paediatr. 2004;93:1437–1442
  106. Ross DA. Recommendations for vitamin A supplementation. J Nutr. 2002;132(Suppl 9):S2902–S2906
  107. Maberly GF, Haxton DP, van der Haar F. Iodine deficiency: consequences and progress toward elimination. Food Nutr Bull. 2003;24(Suppl 4):S91–S98
  108. WHO. Iodine Status Worldwide (WHO Global Database on Iodine Deficiency). Geneva: World Health Organization; 2004;[cited 2007 May 26]. Available from: http://whqlibdoc.who.int/publications/2004/9241592001.pdf.
  109. Bhatnagar S, Natchu UC. Zinc in child health and disease. Indian J Pediatr. 2004;71:991–995
  110. Shrimpton R, Gross R, Darnton-Hill I, Young M. Zinc deficiency: what are the most appropriate interventions?. BMJ. 2005;330:347–349
  111. Black MM. Micronutrient deficiencies and cognitive functioning. J Nutr. 2003;133(11 Suppl 2):S3927–S3931
  112. Bhutta ZA, Black RE, Brown KH, Gardner JM, Gore S, Hidayat A, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials (Zinc Investigators’ Collaborative Group). J Pediatr. 1999;135:689–697
  113. Black RE. Zinc deficiency, infectious disease and mortality in the developing world. J Nutr. 2003;133(5 Suppl 1):S1485–S1489
  114. Bhutta ZA, Bird SM, Black RE, Brown KH, Gardner JM, Hidayat A, et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr. 2000;72:1516–1522
  115. Brooks WA, Yunus M, Santosham M, Wahed MA, Nahar K, Yeasmin S, et al. Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet. 2004;363:1683–1688
  116. Thacher TD, Fischer PR, Strand MA, Pettifor JM. Nutritional rickets around the world: causes and future directions. Ann Trop Paediatr. 2006;26:1–16
  117. Stoltzfus RJ. Iron deficiency: global prevalence and consequences. Food Nutr Bull. 2003;24(Suppl 4):S99–S103
  118. Ronsmans C, Graham WJ. Maternal mortality: who, when, where, and why. Lancet. 2006;368:1189–1200
  119. Mannar MG. Successful food-based programmes, supplementation and fortification. J Pediatr Gastroenterol Nutr. 2006;43(Suppl 3):S47–S53
  120. Zlotkin SH, Schauer C, Christofides A, Sharieff W, Tondeur MC, Hyder SM. Micronutrient sprinkles to control childhood anaemia. PLoS Med. 2005;2:e1
  121. Smuts CM, Lombard CJ, Benade AJ, Dhansay MA, Berger J, Hop le T, et al. Efficacy of a foodlet-based multiple micronutrient supplement for preventing growth faltering, anemia, and micronutrient deficiency of infants: the four country IRIS trial pooled data analysis. J Nutr. 2005;135:S631–S638
  122. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 2006;3:e102
  123. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367:1521–1532
  124. Hotez PJ, Bundy DAP, Beegle K, Brooker LD, de Silva N, Montresor A, et al. Helminth infections: soil-transmitted helminth infections and schistosomiasis. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB, et al. editor. Disease control priorities in developing countries. 2nd edition. New York: Oxford University Press; 2006;p. 467–482[cited 2007 May 26]. Available from: http://www.dcp2.org/pubs/DCP.
  125. Gilles HM. Soil-transmitted Helminths (Geohelminths). In:  Cook GC,  Zumla A editor. Manson’s tropical diseases. 21st edition. London: Elsevier Science; 2003;p. 1527–1560
  126. Gryseels B, Polman K, Clerinx J, Kestens L. Schistosomiasis. Lancet. 2006;368:1106–1118
  127. WHO. Prevention and Control of Schistosomiasis and Soil Transmitted Helminths. Geneva: WHO; 2002;[cited 2007 April 27]. Available from: http://www.who.int/wormcontrol/documents/joint_statements/en/ppc_unicef_finalreport.pdf.
  128. World Health Organization (WHO). Schistosomiasis and soil-transmitted helminth infections – preliminary estimates of the number of children treated with albendazole or mebendazole. Wkly Epidemiolog Rec. 2006;15:145–164
  129. WHO. Scaling up schistosomiasis and soil-transmitted helminthiasis control. Report from meeting of Members of the Partners for Parasite Control, 14-15 December Geneva: WHO; 2006;[cited 2007 June 20]. Available from: http://www.who.int/neglected_diseases/scalingup/en/index.html.
  130. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B. Developmental potential in the first 5 years for children in developing countries. Lancet. 2007;369:60–70
  131. Walker SP, Wachs TD, Gardner JM, Lozoff B, Wasserman GA, Pollitt E, et al. Child development: risk factors for adverse outcomes in developing countries. Lancet. 2007;369:145–157
  132. Engle PL, Black MM, Behrman JR, Cabral de Mello M, Gertler PJ, Kapiriri L, et al. Strategies to avoid the loss of developmental potential in more than 200 million children in the developing world. Lancet. 2007;369:229–242
  133. Olness K. Effects on brain development leading to cognitive impairment: a worldwide epidemic. J Dev Behav Pediatr. 2003;24:120–130
  134. Galler JR, Ramsey FC, Forde V, Salt P, Archer E. Long-term effects of early kwashiorkor compared with marasmus (II. Intellectual performance). J Pediatr Gastroenterol Nutr. 1987;6:847–854
  135. Grantham-McGregor SM, Powell CA, Walker SP, Himes JH. Nutritional supplementation, psychosocial stimulation, and mental development of stunted children: the Jamaican Study. Lancet. 1991;338:1–5
  136. Grantham-McGregor S, Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr. 2001;131:S649–S666
  137. Lozoff B, Jimenez E, Smith JB. Double burden of iron deficiency in infancy and low socioeconomic status: a longitudinal analysis of cognitive test scores to age 19 years. Arch Pediatr Adolesc Med. 2006;160:1108–1113
  138. Iannotti LL, Tielsch JM, Black MM, Black RE. Iron supplementation in early childhood: health benefits and risks. Am J Clin Nutr. 2006;84:1261–1276
  139. Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics. 2007;119:e360–e366
  140. Olusanya BO, Newton VE. Global burden of childhood hearing impairment and disease control priorities for developing countries. Lancet. 2007;369:1314–1317
  141. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why?. Lancet. 2005;365:891–900
  142. Lawn JEZJ, Begkoyian G, Knippenberg R. Newborn survival. In:  Dean JTBJG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB, et al. editor. Disease control priorities in developing countries. 2nd Edition. New York: Oxford University Press; 2006;p. 531–549[cited 2007 May 26]. Available from: http://www.dcp2.org/pubs/DCP.
  143. Knippenberg R, Lawn JE, Darmstadt GL, Begkoyian G, Fogstad H, Walelign N, et al. Systematic scaling up of neonatal care in countries. Lancet. 2005;365:1087–1098
  144. Martines J, Paul VK, Bhutta ZA, Koblinsky M, Soucat A, Walker N, et al. Neonatal survival: a call for action. Lancet. 2005;365:1189–1197
  145. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066–1074
  146. Stanton C, Lawn JE, Rahman H, Wilczynska-Ketende K, Hill K. Stillbirth rates: delivering estimates in 190 countries. Lancet. 2006;367:1487–1494
  147. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS. How many child deaths can we prevent this year?. Lancet. 2003;362:65–71
  148. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. Lancet. 2000;355:451–455
  149. Caulfield LE, Huffman SL, Piwoz EG. Interventions to improve intake of complementary foods by infants 6 to 12 months of age in developing countries: impact on growth and on the prevalence of malnutrition and potential contribution to child survival. Food Nutr Bull. 1999;20:183–200
  150. Fewtrell L, Kaufmann RB, Kay D, Enanoria W, Haller L, Colford JM. Water, sanitation, and hygiene interventions to reduce diarrhoea in less developed countries: a systematic review and meta-analysis. Lancet Infect Dis. 2005;5:42–52
  151. Esrey SA, Potash JB, Roberts L, Shiff C. Effects of improved water supply and sanitation on ascariasis, diarrhoea, dracunculiasis, hookworm infection, schistosomiasis, and trachoma. Bull World Health Organ. 1991;69:609–621
  152. Luby SP, Agboatwalla M, Feikin DR, Painter J, Billhimer W, Altaf A, et al. Effect of handwashing on child health: a randomised controlled trial. Lancet. 2005;366:225–233
  153. Victora CG, Adam T, Bryce J, Evans DB. Integrated management of the sick child. In:  Jamison DT,  Breman JG,  Measham AR,  Alleyne G,  Claeson M,  Evans DB, et al. editor. Disease control priorities in developing countries. 2nd Edition. New York: Oxford University Press; 2006;p. 1177–1191[cited 2007 May 26]. Available from: http://www.dcp2.org/pubs/DCP.
  154. WHO. Handbook: IMCI integrated management of childhood illness. Geneva: WHO; 2005;[cited 2007 May 19]. Available from: http://www.who.int/child-adolescent-health/New_Publications/IMCI/WHO_FCH_CAH_00.12/IMCI_Handbook.pdf.
  155. Armstrong Schellenberg J, Bryce J, de Savigny D, Lambrechts T, Mbuya C, Mgalula L, et al. The effect of Integrated Management of Childhood Illness on observed quality of care of under-fives in rural Tanzania. Health Policy Plan. 2004;19:1–10
  156. Armstrong Schellenberg JR, Adam T, Mshinda H, Masanja H, Kabadi G, Mukasa O, et al. Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in Tanzania. Lancet. 2004;364:1583–1594
  157. Huicho L, Davila M, Gonzales F, Drasbek C, Bryce J, Victora CG. Implementation of the Integrated Management of Childhood Illness strategy in Peru and its association with health indicators: an ecological analysis. Health Policy Plan. 2005;20(Suppl 1):i32–i41
  158. El Arifeen S, Blum LS, Hoque DM, Chowdury EK, Khan R, Black RE, et al. Integrated Management of Childhood Illness (IMCI) in Bangladesh: early findings from a cluster-randomised study. Lancet. 2004;364:1595–1602
  159. Bryce J, Victora CG, Habicht JP, Vaughan JP, Black RE. The multi-country evaluation of the integrated management of childhood illness strategy: lessons for the evaluation of public health interventions. Am J Public Health. 2004;94:406–415
  160. Bryce J, Terreri N, Victora CG, Mason E, Daelmans B, Bhutta ZA, et al. Countdown to 2015: tracking intervention coverage for child survival. Lancet. 2006;368:1067–1076
  161. Claeson M, Gillespie D, Mshinda H, Troedsson H, Victora CG. Knowledge into action for child survival. Lancet. 2003;362:323–327
  162. Victora CG, Fenn B, Bryce J, Kirkwood BR. Co-coverage of preventive interventions and implications for child-survival strategies: evidence from national surveys. Lancet. 2005;366:1460–1466
  163. Fotso JC. Child health inequities in developing countries: differences across urban and rural areas. Int J Equity Health. 2006;5:9
  164. Schellenberg JA, Victora CG, Mushi A, de Savigny D, Schellenberg D, Mshinda H, et al. Inequities among the very poor: health care for children in rural southern Tanzania. Lancet. 2003;361:561–566
  165. Wirth ME, Balk D, Delamonica E, Storeygard A, Sacks E, Minujin A. Setting the stage for equity-sensitive monitoring of the maternal and child health millennium development goals. Bull World Health Organ. 2006;84:519–527
  166. Victora CG, Huicho L, Amaral JJ, Armstrong-Schellenberg J, Manzi F, Mason E, et al. Are health interventions implemented where they are most needed? (District uptake of the integrated management of childhood illness strategy in Brazil, Peru and the United Republic of Tanzania). Bull World Health Organ. 2006;84:792–801

PII: S1538-5442(07)00060-0

doi: 10.1016/j.cppeds.2007.07.003

Current Problems in Pediatric and Adolescent Health Care
Volume 37, Issue 9 , Pages 338-362 , October 2007

Article Tools

* Image Usage & Resolution